Levomethadone

DB13515InvestigationalSmall molecule

Levomethadone is a long-acting opioid agonist used clinically to manage opioid dependency. It is the racemate of methadone and is twice as potent.

Chemical structure of Levomethadone
Mechanism
Curator reviewed
Formula / weight
C21H27NO · 309.453 g/mol (avg)
Also known as
l-methadone

Resolves to

Compound
UNII6Y75Z4E8NSCAS125-58-6ChEMBLCHEMBL159659ChEBI136003
Clinical / RWD
RxNorm236913ATCN07BC05
Structure
InChIKeyUSSIQXCVUWKGNF-QGZVFWFLSA-NSMILESCCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Targets
P35372OPRM1Q15858SCN9AQ12809KCNH2

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
4ContraindicationsEach with its own population and attribute set
Sign in
67Marketed productsAcross 2 countries and 5 labellers
Sign in
1ATC codeIncluding every combination product, plus 3 drug categories
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Levomethadone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In